Table 4. Reproductive characteristics, hormonal levels and reproductive outcomes in artificial insemination (AI) cycles according to anti-Müllerian hormone (AMH) values.
‘Low’ AMH
(<4.08ng/mL)
(n=29)
‘Middle’ AMH
(4.08-8.99ng/mL)
(n=58)
‘High’ AMH
(>8.99ng/mL)
(n=29)
p-value
Age (years) 32.76±3.48 31.17±4.75 29.79±4.09 0.018a,c
BMI (kg/m2) 24.53±3.38 25.95±5.37 27.12±5.67 NSa
FSH (mIU/mL) 6.97±1.33 6.27±1.60 6.07±1.67 0.026a,c
LH (mIU/mL) 9.09±6.16 8.67±3.19 13.25±7.49 0.025a,c, 0.018a,d
LH/FSH ratio 1.29±0.73 1.40±0.41 2.13±1.06 <0.001a,c, 0.006a,d
Positive β-HCG [n (%)] 10 (27) 19 (51.4) 8 (21.6) NSb
Live birth [n (%)] 8 (29.6) 12 (44.4) 7 (25.9) NSb
Miscarriage [n (%)] 1 (25) 4 (80) 0 (0) NSb
Term birth [n (%)] 7 (30.4) 10 (43.5) 6 (26.1) NSb

Values expressed as mean±standard deviation (SD). p-value < 0.05 was considered statistically significant. AMH: anti-Müllerian hormone; BMI: body mass index;
FSH: follicle-stimulating hormone; LH: luteinizing hormone; β-HCG: beta-human chorionic gonadotropin; IU: international units; NS: not statistically significant.
aANOVA test complemented with Kruskal-Wallis test. bChi-square test. cLow-high comparison. dMiddle-high comparison.